NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01703000

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01703000
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Australia, New Zealand, Singapore (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01703000. Allocation not applicable; no masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2013-03 (actual). Results posted on 2014-03-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
Condition
Atherosclerosis
Intervention (Device)
Percutaneous coronary intervention (NG PROMUS)
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01703000
Content hash
f6aa943bb6f97241fcf2bfc1aea2a1d68546e5ccf6528010bae12ea3a6c2256b